Semaglutide vs Phentermine vs Contrave: Three Generations of Weight Loss Drugs Compared

Weight loss medications have evolved dramatically over the past three decades. From the stimulant-based approach of phentermine in the 1990s to the combination therapy of Contrave in the 2010s, and now to the GLP-1 revolution led by semaglutide, each generation represents a fundamental shift in how we approach pharmacological weight management.

This comparison examines three distinct therapeutic approaches that span different decades, mechanisms of action, and patient populations. Understanding these differences helps you make an informed decision based on your specific health profile, budget constraints, and weight loss goals.

Semaglutide: The GLP-1 Revolution

Semaglutide represents the newest generation of weight loss medications, approved by the FDA in 2021 under the brand name Wegovy. This GLP-1 receptor agonist mimics a hormone naturally produced in your intestines that regulates blood sugar and slows gastric emptying.

Key Strengths:

• Delivers the highest average weight loss of any FDA-approved medication (12-15% of body weight)
• Provides comprehensive metabolic benefits including improved insulin sensitivity and cardiovascular outcomes
• Suitable for long-term use with sustained efficacy demonstrated in clinical trials lasting up to 68 weeks
• Weekly injection format improves adherence compared to daily medications

Key Weaknesses:

• Highest cost among the three options, ranging from $199 monthly for compounded versions to $1,349 for brand-name Wegovy
• Injectable administration may deter needle-phobic patients
• Gastrointestinal side effects including nausea, vomiting, and diarrhea affect 20-30% of users initially
• Limited long-term safety data compared to older medications

Clinical trials demonstrate semaglutide's superiority in weight reduction. The STEP 1 trial showed participants lost an average of 14.9% of their body weight over 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). Additionally, 83.5% of participants achieved at least 5% weight loss, and 66.1% achieved 10% or greater weight loss.

The medication works through multiple mechanisms: reducing appetite through central nervous system effects, slowing gastric emptying to increase satiety, and improving glucose-dependent insulin secretion. These combined effects create a powerful tool for sustainable weight management.

Compounded semaglutide options from physician-supervised clinics like FormBlends offer more affordable access to this breakthrough therapy, with prices starting at $199 monthly compared to over $1,000 for brand-name versions.

Phentermine: The Time-Tested Appetite Suppressant

Phentermine has served as the gold standard for short-term weight loss since its FDA approval in 1959. This sympathomimetic amine works as a central nervous system stimulant, suppressing appetite through effects on norepinephrine, dopamine, and serotonin neurotransmitters.

Key Strengths:

• Most affordable option with generic versions costing $30-$100 monthly
• Rapid onset of action with appetite suppression typically beginning within hours
• Extensive safety profile established through decades of clinical use
• Oral administration preferred by patients avoiding injections
• Often covered by insurance plans as a first-line therapy

Key Weaknesses:

• Limited to 3-month treatment courses due to tolerance development and dependency concerns
• Stimulant effects can cause insomnia, anxiety, and elevated blood pressure
• Contraindicated in patients with cardiovascular disease, hyperthyroidism, or glaucoma
• Weight regain common after discontinuation without lifestyle modifications

Meta-analyses show phentermine produces 5-10% body weight reduction during short-term use, with the most significant losses occurring in the first 4-6 weeks of treatment (Hendricks et al., Obesity, 2011). The medication's effectiveness stems from its ability to reduce caloric intake by 200-400 calories daily through appetite suppression.

Phentermine's stimulant properties require careful patient selection. Blood pressure monitoring is essential, as the medication can increase systolic pressure by 5-10 mmHg in some patients. Heart rate elevation of 10-15 beats per minute is also common, making it unsuitable for patients with existing cardiovascular conditions.

The medication's short-term limitation represents both a strength and weakness. While this prevents long-term dependency issues, it also means patients must achieve significant lifestyle changes within the 3-month window to maintain weight loss benefits.

Contrave: The Combination Approach

Contrave combines two existing medications, bupropion and naltrexone, in a novel approach approved by the FDA in 2014. Bupropion, an antidepressant, affects dopamine and norepinephrine pathways, while naltrexone, an opioid antagonist, blocks reward pathways associated with food consumption.

Key Strengths:

• Dual mechanism addresses both appetite control and reward-based eating behaviors
• Particularly effective for patients with emotional eating or food addiction patterns
• Approved for long-term use without the tolerance issues seen with stimulants
• May provide mood benefits through bupropion's antidepressant effects
• Oral administration with twice-daily dosing

Key Weaknesses:

• Moderate weight loss results (5-8% body weight) compared to semaglutide
• Complex titration schedule requiring 4 weeks to reach full dose
• Contraindicated with opioid medications or in patients with eating disorders
• Potential for neuropsychiatric side effects including mood changes and suicidal ideation
• Higher discontinuation rates due to side effects compared to other options

The COR-I and COR-II trials demonstrated Contrave's efficacy, with participants achieving 6.1% and 6.4% weight loss respectively over 56 weeks, compared to 1.3% and 1.8% with placebo (Greenway et al., Lancet, 2010). Notably, 48% of Contrave users achieved 5% or greater weight loss, and 25% achieved 10% or greater weight loss.

Contrave's unique mechanism makes it particularly valuable for patients whose weight gain stems from emotional eating, stress-related consumption, or reward-seeking behaviors around food. The naltrexone component specifically targets the brain's reward pathways, reducing the pleasure and craving associated with high-calorie foods.

The medication requires careful monitoring for neuropsychiatric effects, particularly during the first 8 weeks of treatment. Patients with a history of depression, bipolar disorder, or suicidal ideation require especially close supervision when initiating therapy.

Price Showdown: Who's Cheapest?

Winner: Phentermine

Phentermine dominates the affordability category with generic versions available for $30-$100 monthly. Most insurance plans cover phentermine as a first-line weight loss medication, often requiring only a $10-$30 copay for insured patients.

Contrave occupies the middle ground at $150-$300 monthly for brand-name versions. Generic formulations became available in 2023, reducing costs to $100-$200 monthly. Insurance coverage varies significantly, with some plans covering 50-80% of costs while others exclude weight loss medications entirely.

Semaglutide represents the premium option with brand-name Wegovy costing $1,349 monthly without insurance. However, compounded versions from licensed pharmacies offer substantial savings, with prices ranging from $199-$399 monthly depending on dosage and provider. Insurance coverage for semaglutide remains limited, though some plans now cover it for patients with diabetes or documented cardiovascular risk factors.

Cost-effectiveness calculations must consider treatment duration and outcomes. While phentermine offers the lowest upfront cost, its 3-month limitation may require multiple treatment cycles. Semaglutide's higher monthly cost may prove more economical over time given its superior weight loss results and potential for sustained use.

Medication Selection: Who Offers What?

Winner: Semaglutide (tied with comprehensive providers)

Semaglutide availability has expanded rapidly since 2021, with options ranging from brand-name Wegovy to compounded formulations. Compounding pharmacies can adjust dosing more precisely and often provide additional support medications to manage side effects.

Phentermine remains widely available through most healthcare providers, pharmacies, and weight loss clinics. Its generic status ensures consistent supply and competitive pricing across multiple manufacturers.

Contrave availability improved following generic approval in 2023, though some pharmacies may not stock all formulations. The medication's complex titration schedule requires careful coordination between prescribers and pharmacists.

Telehealth providers increasingly offer all three options, with FormBlends providing physician-supervised access to compounded semaglutide alongside traditional options. This approach combines convenience with clinical oversight, ensuring appropriate patient selection and monitoring.

Doctor Quality: Who Has Real Oversight?

Winner: Physician-supervised telehealth clinics

The quality of medical oversight varies dramatically across different prescribing models. Traditional healthcare systems often provide the most comprehensive evaluation but may have limited appointment availability and higher costs.

Telehealth platforms specializing in weight management typically offer more accessible care with physicians trained specifically in obesity medicine. FormBlends exemplifies this model with board-certified physicians conducting thorough assessments before prescribing any weight loss medication.

Some online providers use nurse practitioners or physician assistants for initial evaluations, which can be appropriate for straightforward cases but may lack the depth needed for complex medical histories or multiple comorbidities.

Red flags include providers offering medications without comprehensive medical history review, those promising specific weight loss amounts, or services that don't require regular follow-up appointments. Quality providers emphasize lifestyle counseling alongside medication management.

Speed: Who Ships Fastest?

Winner: Local pharmacies for phentermine, compounding pharmacies for semaglutide

Phentermine's widespread availability means most local pharmacies can fill prescriptions within 24 hours. Generic formulations are typically in stock, allowing same-day pickup in many cases.

Contrave may require 1-3 days for pharmacies to order if not routinely stocked. The brand-name version is more readily available than generic formulations at some locations.

Semaglutide availability depends on the specific formulation. Brand-name Wegovy often faces supply constraints, with wait times extending 2-4 weeks. Compounded semaglutide from specialized pharmacies typically ships within 3-5 business days, offering faster access at lower cost.

Telehealth providers often partner with specific pharmacies to simplify fulfillment. This can reduce wait times to 2-3 days for most medications, including expedited shipping options for urgent cases.

Which One Should You Choose? Our Recommendations

Selecting the optimal weight loss medication requires matching your specific circumstances, health profile, and goals with each option's strengths and limitations. Here's how to manage these choices based on common scenarios.

Best if you're on a tight budget

Choose: Phentermine

If cost is your primary concern and you're committed to making significant lifestyle changes within a 3-month window, phentermine offers the most affordable entry point. Generic versions cost $30-$100 monthly, and most insurance plans provide coverage. The key to success with phentermine lies in using the appetite suppression window to establish sustainable eating habits and exercise routines that will maintain weight loss after discontinuation.

Ideal candidates for budget-conscious phentermine use include otherwise healthy individuals under 65 with BMI over 30, no cardiovascular disease, and strong motivation for lifestyle modification. The short treatment duration actually works in your favor if you're disciplined about habit formation.

Best if you want premium physician oversight

Choose: Semaglutide through physician-supervised telehealth

For comprehensive medical management with the most effective medication available, semaglutide through a physician-supervised program provides optimal outcomes. The medication's complexity requires ongoing monitoring for side effects, dose adjustments, and coordination with other health conditions.

FormBlends exemplifies this approach with board-certified physicians conducting detailed assessments, regular follow-up appointments, and 24/7 medical support. The higher cost reflects not just the medication but comprehensive care including nutritional counseling, lifestyle coaching, and management of side effects or complications.

Best if you need it fast

Choose: Phentermine from local providers

When time is critical and you need immediate appetite suppression, phentermine's widespread availability and rapid onset make it the fastest option. Most primary care physicians can prescribe it, local pharmacies stock it routinely, and effects begin within hours of the first dose.

This speed advantage makes phentermine valuable for jump-starting weight loss before major life events, medical procedures, or when motivation is at its peak. The key is having a clear plan for transitioning to long-term strategies before the 3-month limit expires.

Best for long-term comprehensive support

Choose: Semaglutide with lifestyle program integration

For sustainable, long-term weight management with the highest probability of success, semaglutide combined with comprehensive lifestyle support offers the best outcomes. The medication's ability to be used for years, combined with its superior weight loss results, justifies the higher investment for most patients.

Look for providers who integrate medication management with nutritional counseling, exercise guidance, behavioral therapy, and ongoing medical monitoring. This whole-body approach addresses the multiple factors contributing to weight gain while maximizing the medication's benefits.

What Each Provider Could Improve

Even the best weight loss medications have areas for improvement that could enhance patient outcomes and accessibility.

Semaglutide providers need to address cost barriers more aggressively. While compounded versions help, the price gap between semaglutide and other options remains substantial. Additionally, better management protocols for gastrointestinal side effects could reduce the 15-20% discontinuation rate seen in clinical practice.

Phentermine prescribers should develop better strategies for maintaining weight loss after the 3-month limit. Too many providers prescribe phentermine without adequate lifestyle counseling or transition planning, leading to weight regain. Extended support programs or combination approaches could improve long-term outcomes.

Contrave manufacturers need to simplify the complex titration schedule that contributes to early discontinuation. A more straightforward dosing regimen could improve adherence and reduce the learning curve for both patients and providers.

The weight loss medication field would benefit from better insurance coverage policies that recognize obesity as a chronic medical condition requiring long-term treatment, not a cosmetic concern deserving limited support.

Clinical Outcomes: What the Research Really Shows

Understanding the clinical evidence behind each medication helps set realistic expectations and guides appropriate patient selection. Head-to-head trials are limited, but individual studies provide clear outcome data.

Semaglutide demonstrates the most strong weight loss results across multiple large-scale trials. The STEP program included over 4,500 participants across different populations, consistently showing 12-15% average weight loss. Importantly, these results were sustained throughout the study periods, with minimal weight regain as long as treatment continued (Davies et al., Lancet, 2021).

Phentermine studies typically show 5-10% weight loss during the 3-month treatment period, with most benefit occurring in the first 6-8 weeks. A comprehensive meta-analysis of 13 trials found average weight loss of 6.3 kg (13.9 lbs) compared to placebo over 2-24 weeks (Hendricks et al., Obesity, 2011). However, follow-up studies reveal significant weight regain within 6 months of discontinuation without lifestyle interventions.

Contrave trials demonstrate consistent but moderate weight loss, with the COR trials showing 5-6% average reduction over 56 weeks. The medication's strength lies in sustained effect over time, with weight loss plateauing around 6 months but remaining stable throughout extended treatment periods (Greenway et al., Lancet, 2010).

Safety profiles differ significantly among the three options. Semaglutide's most common side effects are gastrointestinal, typically mild to moderate and improving over time. Phentermine's stimulant effects can cause cardiovascular complications in susceptible patients. Contrave carries warnings for neuropsychiatric effects and seizure risk in predisposed individuals.

Insurance and Access Considerations

Insurance coverage for weight loss medications varies dramatically based on your plan type, employer policies, and state regulations. Understanding these nuances helps you budget appropriately and explore all available options.

Phentermine enjoys the broadest insurance coverage as an established, generic medication. Most commercial plans cover it with standard prescription copays, typically $10-$50 monthly. Medicare Part D plans increasingly include phentermine, though coverage varies by specific plan.

Contrave coverage depends heavily on your specific insurance plan. Some commercial insurers cover it with prior authorization, requiring documentation of BMI over 30 and failed attempts with other weight loss methods. Generic versions improved coverage rates, but many plans still exclude weight loss medications entirely.

Semaglutide presents the most complex insurance field. Coverage for Wegovy (the weight loss formulation) remains limited, with most plans requiring extensive prior authorization including documented obesity-related comorbidities. However, many patients access semaglutide through diabetes coverage (Ozempic) when prescribed off-label for weight loss.

Patient assistance programs can significantly reduce costs for qualifying individuals. Novo Nordisk offers savings programs for Wegovy, while generic manufacturers provide discount cards for phentermine and Contrave. Telehealth providers like FormBlends often negotiate better pricing through volume purchasing and direct pharmacy relationships.

Frequently Asked Questions

Can I switch between these medications if one doesn't work?

Yes, switching between weight loss medications is common and often beneficial. Most physicians recommend trying one medication for 3-4 months before evaluating effectiveness. If you don't achieve 5% weight loss in this timeframe, switching to a different mechanism of action often produces better results. Always work with your healthcare provider to manage transitions safely and avoid drug interactions.

Which medication has the fewest side effects?

Side effect profiles vary by individual tolerance, but generally phentermine causes the most noticeable immediate effects due to its stimulant properties. Semaglutide's gastrointestinal effects are common initially but typically improve over 4-8 weeks. Contrave has the most variable side effect profile, ranging from minimal impact to significant mood changes in susceptible individuals.

Do these medications work without diet and exercise?

All three medications are most effective when combined with lifestyle modifications. Clinical trials showing significant weight loss included dietary counseling and exercise recommendations. While the medications can produce some weight loss independently, combining them with a reduced-calorie diet and increased physical activity typically doubles the weight loss achieved.

How long do I need to take weight loss medication?

Treatment duration varies by medication and individual response. Phentermine is limited to 3-month periods with breaks between courses. Semaglutide and Contrave can be used long-term, with many patients requiring ongoing treatment to maintain weight loss. Stopping these medications typically results in gradual weight regain unless lifestyle changes are well-established.

Are these medications safe for people with diabetes?

Semaglutide is actually beneficial for people with type 2 diabetes, improving blood sugar control while promoting weight loss. Phentermine requires careful monitoring in diabetic patients as it can affect blood glucose levels. Contrave is generally safe for diabetics but may interact with certain diabetes medications. Always inform your prescriber about diabetes and current medications.

Can I get these medications through telehealth?

Yes, all three medications are available through legitimate telehealth providers. Quality telehealth services conduct comprehensive medical evaluations, review lab work when appropriate, and provide ongoing monitoring. Be cautious of providers offering medications without proper medical assessment or those making unrealistic promises about weight loss results.

What happens if I become pregnant while taking these medications?

All three medications should be discontinued immediately if pregnancy occurs or is planned. Semaglutide and Contrave are not recommended during pregnancy or breastfeeding. Phentermine is contraindicated in pregnancy. If you're planning to become pregnant, discuss this with your healthcare provider before starting any weight loss medication to develop an appropriate timeline and alternative strategies.

Making Your Decision: A Practical Framework

Choosing among semaglutide, phentermine, and Contrave requires honest assessment of your priorities, medical history, and commitment level. Use this framework to guide your decision-making process.

Start by evaluating your primary goal. If you need rapid weight loss for a specific event or medical procedure, phentermine's quick onset and proven short-term efficacy make it ideal. For substantial, long-term weight reduction with the highest probability of success, semaglutide's superior clinical outcomes justify the higher cost. If emotional eating or food addiction drives your weight gain, Contrave's dual mechanism specifically addresses these behavioral patterns.

Consider your medical history carefully. Cardiovascular disease, anxiety disorders, or stimulant sensitivity contraindicate phentermine. History of depression, eating disorders, or current opioid use rules out Contrave. Semaglutide has the fewest absolute contraindications but requires caution in patients with gastroparesis or severe gastrointestinal disorders.

Budget constraints significantly impact long-term success. While phentermine offers the lowest upfront cost, repeated cycles may be necessary. Semaglutide's higher monthly cost should be evaluated against its superior efficacy and potential for sustained use. Many patients find compounded semaglutide through providers like FormBlends offers the best balance of effectiveness and affordability.

Your support system and lifestyle factors also matter. Semaglutide's weekly injection requires comfort with self-administration. Contrave's twice-daily dosing demands consistent routine adherence. Phentermine's stimulant effects may interfere with sleep or work performance in sensitive individuals.

Ready to Start Your Weight Loss Goals?

The evidence clearly shows that medically supervised weight loss produces better outcomes than attempting to lose weight alone. Whether you choose the proven affordability of phentermine, the targeted approach of Contrave, or the superior efficacy of semaglutide, working with qualified healthcare providers maximizes your chances of success.

Take our free physician assessment to determine which medication best matches your health profile and weight loss goals. Our board-certified physicians review your medical history, current medications, and individual circumstances to recommend the most appropriate treatment approach.

For patients interested in semaglutide, FormBlends offers physician-supervised compounded semaglutide starting at $199 monthly, making this breakthrough therapy more accessible while maintaining the highest safety standards. Our comprehensive program includes ongoing medical monitoring, nutritional counseling, and 24/7 support to optimize your results.

Don't let another month pass struggling with ineffective approaches. The right medication, combined with professional guidance and lifestyle support, can transform your relationship with weight management. Read what our patients say about their success with medically supervised weight loss programs.

Sources & References

1. Wilding, J.P.H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002.
2. Davies, M., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet, 397(10278), 971-984.
3. Hendricks, E.J., et al. (2011). Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. Obesity, 19(4), 729-735.
4. Greenway, F.L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 376(9741), 595-605.
5. FDA. (2021). Wegovy (semaglutide) injection prescribing information. Accessed March 10, 2026.
6. FDA. (2014). Contrave (naltrexone HCl and bupropion HCl) extended-release tablets prescribing information. Accessed March 10, 2026.
7. Adipex-P (phentermine hydrochloride) prescribing information. Gate Pharmaceuticals. Accessed March 10, 2026.
8. Ryan, D.H., et al. (2010). Nonsurgical weight loss for extreme obesity in primary care settings: a randomized trial. JAMA, 304(16), 1795-1802.